Clinical Trial

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 29, 2023 (before its estimated July 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
There is no clinical study on epidermal growth factor receptor tyrosine kinase inhibitors has been systematically conducted in adenoid cystic carcinoma. This is a phase II study EGFR TKIs in adenoid cystic carcinoma to evaluate its efficacy in this disease.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT04974866
Lead Sponsor Qingdao Central Hospital
Conditions Carcinoma, Adenoid Cystic
Enrollment 20 participants
Start Date 2021-07-01
Primary Completion 2024-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2023-03-29